Evidence map›Paper›PMID 27226416›Full record

ArticleJournal of Crohn's & colitis2016

Critical Role of the Disintegrin Metalloprotease ADAM-like Decysin-1 [ADAMDEC1] for Intestinal Immunity and Inflammation.

Nuala R O'Shea, Thean S Chew, Jenny Dunne, Rebecca Marnane, Bahman Nedjat-Shokouhi, Philip J Smith, Stuart L Bloom, Andrew M Smith, Anthony W Segal

Open access · hybridAbstract read
In one paragraph

Article in Journal of Crohn's & colitis, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 61 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Frontiers in immunology · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Nuala R O'SheaDivision of Medicine, University College London, London, UK.
Thean S ChewDivision of Medicine, University College London, London, UK.
Jenny DunneDivision of Medicine, University College London, London, UK.
Rebecca MarnaneDivision of Medicine, University College London, London, UK.
Bahman Nedjat-ShokouhiDivision of Medicine, University College London, London, UK.
Philip J SmithDivision of Medicine, University College London, London, UK.
Stuart L BloomDepartment of Gastroenterology, University College London Hospital, UK.
Andrew M SmithDivision of Medicine, University College London, London, UK.
Anthony W SegalDivision of Medicine, University College London, London, UK.
University College London · GB

Funding

Medical Research Council G0902005Medical Research Council G0902022Medical Research Council MR/L000261/1Wellcome Trust
6 · The paper itself

Abstract

BACKGROUND AND

aimsADAM [A Disintegrin And Metalloproteinase] is a family of peptidase proteins which have diverse roles in tissue homeostasis and immunity. Here, we study ADAM-like DECysin-1 [ADAMDEC1] a unique member of the ADAM family. ADAMDEC1 expression is restricted to the macrophage/dendritic cell populations of the gastrointestinal tract and secondary lymphoid tissue. The biological function of ADAMDEC1 is unknown but it has been hypothesised to play a role in immunity. The identification of reduced ADAMDEC1 expression in Crohn's disease patients has provided evidence of a potential role in bowel inflammation.

methodsAdamdec1

resultsThe loss of Adamdec1 rendered mice more susceptible to the induction of bacterial and chemical induced colitis, as evidenced by increased neutrophil infiltration, greater IL-6 and IL-1β secretion, more weight loss and increased mortality. In the absence of Adamdec1, greater numbers of Citrobacter rodentium were found in the spleen, suggestive of a breakdown in mucosal immunity which resulted in bacteraemia.

conclusionIn summary, ADAMDEC1 protects the bowel from chemical and bacterial insults, failure of which may predispose to Crohn's disease.

Indexed as

ADAM ProteinsAnimalsCitrobacter rodentiumColitisColonDextran SulfateDisease Models, AnimalEnterobacteriaceae InfectionsIntestinal MucosaMiceMice, Inbred C57BLSalmonella Infections, AnimalSalmonella typhimuriumAdamdec1 protein, mouseADAM ProteinsdecysinDextran SulfateCitrobacter rodentiumcolitisDSS

Identifiers

PMID27226416
PMCPMC5174729
OpenAlexW2405201977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.